Concord Biotech Limited (NSE:CONCORDBIO)
India · Delayed Price · Currency is INR 1,419.90
+89.90 (6.76%)
Jul 31, 2026, 3:30 PM IST
Concord Biotech Market Cap
Concord Biotech has a market cap or net worth of 148.64 billion as of July 31, 2026. Its market cap has decreased by -22.11% in one year.
Market Cap
148.64B
Enterprise Value
144.32B
Revenue
11.08B
Ranking
n/a
PE Ratio
54.15
Stock Price
1,419.90
ChartMarket Cap Chart
Since August 18, 2023, Concord Biotech's market cap has increased from 98.63B to 148.64B, an increase of 50.70%. That is a compound annual growth rate of 14.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 148.64B | 5.59% |
| Dec 31, 2025 | 140.77B | -39.13% |
| Dec 31, 2024 | 231.28B | 50.21% |
| Dec 29, 2023 | 153.97B | 56.11% |
| Aug 18, 2023 | 98.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 689.42B |
| Anthem Biosciences | 455.74B |
| OneSource Specialty Pharma | 185.69B |
| Blue Jet Healthcare | 118.53B |
| Supriya Lifescience | 69.78B |
| Zota Health Care | 44.31B |
| Dishman Carbogen Amcis | 29.31B |
| Panacea Biotec | 25.81B |